Patients with radiographic improvement (negative change) in erosion of the hands and feet at week 102 in patients with early RA
| Assessment variable | MTX only | 3 mg/kg Infliximab+MTX | 10 mg/kg Infliximab+MTX | Total infliximab | ||
|---|---|---|---|---|---|---|
| q 8 Weeks | q 4 Weeks | q 8 Weeks | q 4 Weeks | |||
| Results are given as No (%) of patients. | ||||||
| Patients with early RA | 17 | 19 | 19 | 20 | 7 | 65 |
| Patients evaluated | 12 | 10 | 16 | 17 | 6 | 49 |
| Patients with score <−0.5 | 0 (0) | 7 (70) | 7 (44) | 3 (18) | 3 (50) | 20 (41) |
| p Value v placebo | <0.001 | 0.010 | 0.246 | 0.025 | 0.006 | |
| Patients with score <−0.5 and no worsening in any joint of >1 | 0 (0) | 7 (70) | 7 (44) | 3 (18) | 3 (50) | 20 (41) |
| p Value v placebo | <0.001 | 0.010 | 0.246 | 0.025 | 0.006 | |
| Patients with score <−0.5 and no worsening in any joint | 0 (0) | 2 (20) | 5 (31) | 3 (18) | 2 (33) | 12 (24) |
| p Value v placebo | 0.195 | 0.053 | 0.246 | 0.098 | 0.100 | |